日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Accelerating AI innovation in healthcare: real-world clinical research applications on the Mayo Clinic Platform

加速医疗保健领域的人工智能创新：基于梅奥诊所平台的真实世界临床研究应用

期刊:
影响因子:
doi:10.1038/s44401-026-00068-1
Yu, Yue; Hu, Xinyue; Rajaganapathy, Sivaraman; Feng, Jingna; Abdelhameed, Ahmed; Li, Xiaodi; Li, Jianfu; Liu, Xiaoke; Yang, Liu; Ertekin-Taner, Nilüfer; Fiero, Phil; Boroumand, Soulmaz; Larsen, Richard; Goyal, Maneesh; Otley, Clark C; Zong, Nansu; Shah, Vijay H; Halamka, John D; Tao, Cui
发表日期：2026
文献求助 收藏

FDA Approval Summary: Niraparib plus Abiraterone Acetate Fixed-Dose Combination for BRCA-Mutated Metastatic Castration-Resistant Prostate Cancer

FDA批准摘要：尼拉帕尼联合醋酸阿比特龙固定剂量组合用于治疗BRCA突变转移性去势抵抗性前列腺癌

期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-25-0883
Maguire, William F; Chi, Dow-Chung; Agrawal, Sundeep; Joeng, Hee-Koung; Kim-McOlash, Sarah; Manheng, Wimolnut; Bulatao, Ilynn; Sanchez-Solana, Beatriz; Pathak, Anand; Lee, Alice; Han, Yu; Ricks, Tiffany K; Hamed, Salaheldin S; Fiero, Mallorie H; Pierce, William F; Kalavar, Shyam; Ghosh, Soma; Leighton, John K; Tang, Shenghui; Amiri-Kordestani, Laleh; Kluetz, Paul G; Suzman, Daniel L
肿瘤
前列腺癌
肿瘤免疫
发表日期：2025
文献求助 收藏

FDA Approval Summary: Nogapendekin Alfa Inbakicept-pmln with BCG for BCG-Unresponsive Carcinoma In Situ

FDA批准摘要：诺加潘地金α（Nogapendekin Alfa）联合卡介苗（BCG）治疗对卡介苗无反应的原位癌

期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-25-1231
Heiss, Brian L; Chang, Elaine; Joeng, Hee-Koung; Fiero, Mallorie H; Wang, Lingshan; Hamed, Salaheldin S; Chiu, Haw-Jyh; Ricks, Tiffany K; Koh, Eun Hee; Dellibovi-Ragheb, Teegan A; Wang, Min; Lee, Christal; Pierce, William F; Leighton, John K; Rahman, Nam Atiqur; Tang, Shenghui; Pazdur, Richard; Amiri-Kordestani, Laleh; Kluetz, Paul G; Suzman, Daniel L
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Longitudinal graphics of patient-reported physical function in patients treated for hematologic malignancies

接受血液系统恶性肿瘤治疗的患者自述身体功能的纵向图表

期刊:BMC Medical Research Methodology
影响因子:3.4
doi:10.1186/s12874-025-02617-y
Thanarajasingam, Gita; Bhatnagar, Vishal; Noble, Brie N; Chen, Ting-Yu; Fiero, Mallorie H; Hoffman, Ron; Jeffery, Molly; Mazza, Gina L; Mascarenhas, John; Mesa, Ruben; Murugappan, Meena; Ross, Joseph; Sidana, Surbhi; Warsame, Rahma; Kluetz, Paul G; Dueck, Amylou C
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Cardiac Adverse Events in Patients Receiving Immune Checkpoint Inhibitors in the Adjuvant Setting: An FDA Pooled Analysis

接受免疫检查点抑制剂辅助治疗的患者发生心脏不良事件：FDA汇总分析

期刊:Annals of Noninvasive Electrocardiology
影响因子:1
doi:10.1111/anec.70087
Dilawari, Asma; Krantz, Mori J; Bulatao, Ilynn; Joeng, Hee-Koung; Neilson, Marc; Wedam, Suparna; Gao, Xin; Fiero, Mallorie H; Nair, Abhilasha; Theoret, Marc; Amiri-Kordestani, Laleh
Checkpoint
发表日期：2025
文献求助 收藏

First 3 Minutes: A Rapid Cycle Deliberate Practice Pediatric Resuscitation Simulation for Multidisciplinary Staff

前3分钟：多学科团队儿科复苏快速循环刻意练习模拟

期刊:MedEdPORTAL : the journal of teaching and learning resources
影响因子:
doi:10.15766/mep_2374-8265.11529
Songer, Kathryn; Fiero, Marie; Roberts, Joan
发表日期：2025
文献求助 收藏

Assessing tolerability of cancer therapeutics: A regulatory perspective from the FDA Oncology Center of Excellence

评估癌症治疗药物的耐受性：来自FDA肿瘤卓越中心的监管视角

期刊:Cancer
影响因子:
doi:10.1002/cncr.35949
Bhatnagar, Vishal; Lee Johnson, Laura; Fiero, Mallorie H; Mulkey, Flora; Kluetz, Paul
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

US Food and Drug Administration Approval Summary: Elacestrant for Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative, ESR1-Mutated Advanced or Metastatic Breast Cancer

美国食品药品监督管理局批准摘要：Elacestrant 用于治疗雌激素受体阳性、人表皮生长因子受体 2 阴性、ESR1 突变的晚期或转移性乳腺癌

期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.23.02112
Shah, Mirat; Lingam, Hima; Gao, Xin; Gittleman, Haley; Fiero, Mallorie H; Krol, Danielle; Biel, Nikolett; Ricks, Tiffany K; Fu, Wentao; Hamed, Salaheldin; Li, Fang; Sun, Jillian Jielin; Fan, Jianghong; Schuck, Robert; Grimstein, Manuela; Tang, Liuya; Kalavar, Shyam; Abukhdeir, Abdelrahmman; Pathak, Anand; Ghosh, Soma; Bulatao, Ilynn; Tilley, Amy; Pierce, William F; Mixter, Bronwyn D; Tang, Shenghui; Pazdur, Richard; Kluetz, Paul; Amiri-Kordestani, Laleh
肿瘤
肿瘤免疫
信号转导
乳腺癌
Human
免疫/内分泌
发表日期：2024
文献求助 收藏

FDA Approval Summary: Enfortumab Vedotin plus Pembrolizumab for Locally Advanced or Metastatic Urothelial Carcinoma

FDA批准摘要：恩福妥单抗联合帕博利珠单抗治疗局部晚期或转移性尿路上皮癌

期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-24-1393
Brave, Michael H; Maguire, William F; Weinstock, Chana; Zhang, Hui; Gao, Xin; Li, Fang; Yu, Jingyu; Fu, Wentao; Zhao, Hong; Pierce, William F; Chang, Elaine; Dinin, Jeannette; Fiero, Mallorie H; Rahman, Nam Atiqur; Tang, Shenghui; Pazdur, Richard; Kluetz, Paul G; Amiri-Kordestani, Laleh; Suzman, Daniel L
肿瘤
肿瘤免疫
发表日期：2024
文献求助 收藏

FDA Approval Summary: Belzutifan for Patients with Advanced Renal Cell Carcinoma

FDA批准摘要：Belzutifan用于治疗晚期肾细胞癌患者

期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-24-1199
Fallah, Jaleh; Heiss, Brian L; Joeng, Hee-Koung; Weinstock, Chana; Gao, Xin; Pierce, William F; Chukwurah, Benjamin; Bhatnagar, Vishal; Fiero, Mallorie H; Amiri-Kordestani, Laleh; Pazdur, Richard; Kluetz, Paul G; Suzman, Daniel L
肿瘤
肾癌
肿瘤免疫
细胞生物学
发表日期：2024
文献求助 收藏